Frontlight ResearchEarly access
CompletedPhase 1
Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers
Key facts
- Who runs it
- Daewon Pharmaceutical Co., Ltd.
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 24 people enrolled
- Started
- 21 Nov 2024
- Ended
- 8 Apr 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- DW4421
- Record updated
- 23 January 2026
Who can take part
- Age
- 19 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Healthy Volunteers who are ≥19 years old
- Body weight ≥50.0 kg and BMI between 18.0 and 30.0 kg/m2
Who cannot take part
- Clinically significant Medical History
- In the case of women, pregnant(Urine-HCG positive) or lactating women
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A Randomized, Open-label, Oral in healthy volunteers
The 2 groups in the trial
- Sequence ATreatment being tested
Cross-over
Treatment: DW4421
- Sequence BTreatment being tested
Cross-over
Treatment: DW4421
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Phase 1 Clinical Trial to Evaluate the Effect of Food on the Safety, Pharmacokinetics and Pharmacodynamics Characteristics of DW4421 in Healthy Adult Volunteers
- Record updated
- 23 January 2026